Preimplantation Genetics, a revolutionary field in reproductive medicine, has transformed the landscape of assisted reproductive technologies, offering a profound understanding and control over the genetic makeup of embryos before implantation. This cutting-edge technique, often referred to as Preimplantation Genetic Testing (PGT), empowers individuals and couples to make informed decisions about their family planning journey, particularly in the context of hereditary genetic conditions. Preimplantation genetics tries to discover and choose embryos with the desired genetic features by doing genetic analysis on embryos formed through in vitro fertilisation (IVF) prior to implantation, thereby reducing the danger of passing down inheritable illnesses to future generations. The primary motivation behind the adoption of preimplantation genetics lies in its potential to prevent the transmission of genetic diseases. Couples carrying a known genetic disorder, be it a single gene disorder like cystic fibrosis or a chromosomal abnormality, face the daunting prospect of passing on the condition to their offspring. Preimplantation Genetic Testing allows these individuals to undergo IVF, and during the early stages of embryo development, a few cells are extracted and analyzed for genetic abnormalities. Only embryos deemed free of the targeted genetic disorder are then selected for implantation, offering a significantly enhanced chance of having a healthy child. Beyond the prevention of genetic diseases, preimplantation genetics plays a pivotal role in fertility treatment by addressing issues such as recurrent pregnancy loss and advanced maternal age. As women age, the risk of chromosomal abnormalities in their eggs increases, leading to a higher likelihood of miscarriage and conditions such as Down syndrome. Preimplantation Genetic Testing for Aneuploidy (PGT-A) evaluates embryos for chromosomal abnormalities, allowing clinicians to select embryos with the correct number of chromosomes, thereby improving the chances of a successful pregnancy and a healthy baby. Preimplantation genetics also extends its applications to family balancing or gender selection, a controversial but increasingly sought-after option by parents aspiring to balance the gender composition of their offspring. By identifying embryos of a specific gender during the genetic testing process, individuals or couples can make more informed choices about family planning, aligning with their preferences or addressing gender-specific genetic conditions.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia